Although present results support previous studies [42, 47, 95, 96], we found novel evidence regarding a significant neurodegenerative progression of FTD in cases with mutations, followed by patients with risk tau haplotypes or APOE variants, and finally sporadic FTD presentations. The gene discussed is APOE; the disease is frontotemporal dementia.